scispace - formally typeset
P

Pam Thomason

Researcher at Royal Children's Hospital

Publications -  58
Citations -  1968

Pam Thomason is an academic researcher from Royal Children's Hospital. The author has contributed to research in topics: Cerebral palsy & Gross Motor Function Classification System. The author has an hindex of 21, co-authored 52 publications receiving 1594 citations.

Papers
More filters
Journal ArticleDOI

Single-event multilevel surgery in children with spastic diplegia: a pilot randomized controlled trial.

TL;DR: This pilot study provides Level-II evidence that single-event multilevel surgery improves the gait of children with spastic diplegic cerebral palsy twelve months after surgery.
Journal ArticleDOI

Does botulinum toxin a combined with bracing prevent hip displacement in children with cerebral palsy and "hips at risk"? A randomized, controlled trial.

TL;DR: There may be a small treatment benefit for the combined intervention of intramuscular injection of botulinum toxin A and abduction hip bracing in the management of spastic hip displacement in children with cerebral palsy.
Journal ArticleDOI

The minimal clinically important difference for the Gait Profile Score.

TL;DR: A rationale for defining an MCID for the Gait Profile Score (GPS) is proposed based on an analysis of the difference in median GPS for children classified at different levels of the Functional Assessment Questionnaire, finding a strong linear correlation between median score and FAQ level.
Journal ArticleDOI

Single Event Multilevel Surgery in children with bilateral spastic cerebral palsy: a 5 year prospective cohort study.

TL;DR: SEMLS results in clinically and statistically significant improvements in gait and function, in children with BSCP, which were maintained at 5 years after surgery.
Journal ArticleDOI

A randomized controlled trial of the impact of therapeutic horse riding on the quality of life, health, and function of children with cerebral palsy

TL;DR: It is suggested that therapeutic horse riding does not have a clinically significant impact on children with CP and a smaller effect cannot be ruled out and the absence of evidence might be explained by a lack of sensitivity of the instruments since the QoL and health measures have not yet been demonstrated to be sensitive to change.